G
Gorana Capkun
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
Oct 5, 2026
Integrated Evidence Planning That Connects Drug Development to Patient Needs
2:10
Can you maybe start with an introduction of yourself? In the pre-chat, we found that we have the same kind of origins in pure mathematics, but where did you go from your studies?
G
2:23Gorana CapkunGUEST
From my studies, yeah, so I left these pure theoretical mathematics to touch on computer science and then discovered statistics, which fascinated me because they try to describe the world by using measurements.
G
2:38Gorana CapkunGUEST
And I was first working in different actually areas outside of healthcare when I discovered epidemiology.
G
2:45Gorana CapkunGUEST
So after my PhD in applied statistics, I moved into the field of epidemiology and was really fascinated about data that are already collected or that we are collecting to understand what is happening in clinical practice and try to get some meaning out of that or guidances out of that, especially when questions are geographically very diverse and wide.
G
3:15Gorana CapkunGUEST
So I worked, uh, in the Swiss Federal Office for Public Health when a really great invitation from Novartis to join their biostatistics department came.
13 MINS LATER
